Currently, Applied Dna Sciences Inc [APDN] is trading at $2.54, up 38.80%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The APDN shares have gain 224.43% over the last week, with a monthly amount glided 497.65%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Applied Dna Sciences Inc [NASDAQ: APDN] stock has seen the most recent analyst activity on February 12, 2021, when ROTH Capital initiated its Buy rating and assigned the stock a price target of $24. Previously, H.C. Wainwright reaffirmed its Buy rating on January 14, 2021, and dropped its price target to $14. On December 18, 2020, H.C. Wainwright reiterated its Buy rating and revised its price target to $12 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $22 on July 20, 2020. H.C. Wainwright initiated its recommendation with a Buy and recommended $18 as its price target on July 02, 2020. Maxim Group reiterated a Buy rating for this stock on November 14, 2016, and downed its price target to $6. In a note dated May 13, 2016, Maxim Group reiterated an Buy rating on this stock and revised its target price from $13 to $9.
This stock has fluctuated between a low of $0.31 and a high of $30.60 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $1.5 within the next 12 months. Applied Dna Sciences Inc [NASDAQ: APDN] shares were valued at $2.54 at the most recent close of the market. An investor can expect a potential drop of -40.94% based on the average APDN price forecast.
Analyzing the APDN fundamentals
Trailing Twelve Months sales for Applied Dna Sciences Inc [NASDAQ:APDN] were 3.40M which represents -72.66% decline. Gross Profit Margin for this corporation currently stands at 0.16% with Operating Profit Margin at -4.39%, Pretax Profit Margin comes in at -2.17%, and Net Profit Margin reading is -2.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.44, Equity is -1.37 and Total Capital is -1.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.85 points at the first support level, and at 1.15 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.39, and for the 2nd resistance point, it is at 4.23.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Applied Dna Sciences Inc [NASDAQ:APDN] is 3.91. Also, the Quick Ratio is 3.76, while the Cash Ratio stands at 3.45. Considering the valuation of this stock, the price to sales ratio is 7.69, the price to book ratio is 2.11.
